InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (12 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
12
T+90 hit rate
100%
T+90 mean return
+5.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Schemick Michael Andrew, Chief Financial Officer. Officer active across 2 companies, notably Certara, Inc.. In total, 15 disclosures have been logged. Split: 1 buy · 12 sells. Total volume traded: €20.4m. History available since 22 June 2021. The latest transaction was filed on 31 March 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
3,721 shares@ US$23.800.4% of flowCommon StockSEC:0001415889-23-005799:0
25,000 shares@ US$16.642.0% of flowCommon StockSEC:0001415889-22-008827:0
Canonical exit: 15 Nov 2022 (T+90)
3,973 shares@ US$21.480.0055% mcap0.4% of flowCommon StockSEC:0001415889-22-003841:0
65,896 shares@ US$37.830.16% mcap10.9% of flowCommon StockSEC:0001415889-21-005221:0
65,896 shares@ US$37.8310.6% of flowCommon StockSEC:0001415889-21-005221
62,049 shares@ US$36.420.14% mcap9.7% of flowCommon StockSEC:0001415889-21-004909:0
62,049 shares@ US$36.429.5% of flowCommon StockSEC:0001415889-21-004909
48,097 shares@ US$34.460.10% mcap7.0% of flowCommon StockSEC:0001415889-21-004508:0
48,097 shares@ US$34.466.9% of flowCommon StockSEC:0001415889-21-004508
65,267 shares@ US$28.217.6% of flowCommon StockSEC:0001415889-21-003956
65,267 shares@ US$28.210.11% mcap7.8% of flowCommon StockSEC:0001415889-21-003956:0
66,667 shares@ US$24.376.7% of flowCommon StockSEC:0001415889-21-003663
66,667 shares@ US$24.370.098% mcap6.9% of flowCommon StockSEC:0001415889-21-003663:0
66,666 shares@ US$26.947.3% of flowCommon StockSEC:0001415889-21-003165
66,666 shares@ US$26.940.11% mcap7.5% of flowCommon StockSEC:0001415889-21-003165:0
15 of 15 declarations
About Schemick Michael Andrew
Michael Andrew Schemick is the Chief Financial Officer of Certara, Inc. In this role, he is responsible for financial management and strategy for the company. Certara, Inc. specializes in modeling and simulation solutions for the biopharmaceutical industry. Michael plays a key role in financial planning and analysis.
